Unlock Premium for Just $9.99/Month – Special Launch Offer, Limited Time Only
Get Premium
HLVX HilleVax Inc
- Stocks
- Healthcare
- NASDAQ: HLVX
Price (delayed)
$2.06
Market cap
$103.29M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$2.16
Enterprise value
$78.21M
Highlights
HLVX's quick ratio has soared by 134% since the previous quarter and by 131% year-on-year
HLVX's debt has dropped by 53% year-on-year
The equity has declined by 37% year-on-year and by 2.3% since the previous quarter
Key stats
What are the main financial stats of HLVX
Market
Valuations
Earnings
Shares outstanding
50.14M
Market cap
$103.29M
Enterprise value
$78.21M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.68
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
Gross profit
$0
Operating income
-$113.1M
Net income
-$106.5M
EBIT
-$103.91M
EBITDA
-$100.93M
Free cash flow
-$88.88M
Per share
Balance sheet
Liquidity
EPS
-$2.16
EPS diluted
-$2.16
Free cash flow per share
-$1.78
Book value per share
$3.01
Revenue per share
$0
TBVPS
$3.58
Total assets
$178.82M
Total liabilities
$27.91M
Debt
$24.04M
Equity
$150.91M
Working capital
$159.16M
Debt to equity
0.16
Current ratio
25.32
Quick ratio
24.62
Net debt/EBITDA
0.25
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-49%
Return on equity
-61.3%
Return on invested capital
-85.3%
Return on capital employed
-60.3%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
HLVX stock price
How has the HilleVax stock price performed over time
Intraday
-2.37%
1 week
5.64%
1 month
5.1%
1 year
-85.39%
YTD
-0.48%
QTD
3.52%
Financial performance
How have HilleVax's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$113.1M
Net income
-$106.5M
Gross margin
N/A
Net margin
N/A
HilleVax's net income has increased by 28% QoQ and by 26% YoY
HilleVax's operating income has increased by 27% QoQ and by 27% YoY
Price vs fundamentals
How does HLVX's price correlate with its fundamentals
Growth
What is HilleVax's growth rate over time
Valuation
What is HilleVax stock price valuation
P/E
N/A
P/B
0.68
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
HLVX's EPS is up by 35% year-on-year and by 28% since the previous quarter
HLVX's price to book (P/B) is 48% less than its last 4 quarters average of 1.3
The equity has declined by 37% year-on-year and by 2.3% since the previous quarter
Efficiency
How efficient is HilleVax business performance
The ROIC has grown by 21% from the previous quarter but it has contracted by 4.7% YoY
HilleVax's ROE has increased by 19% from the previous quarter but it has decreased by 9% YoY
The return on assets has increased by 16% since the previous quarter but it has declined by 12% year-on-year
Dividends
What is HLVX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for HLVX.
Financial health
How did HilleVax financials performed over time
HLVX's quick ratio has soared by 134% since the previous quarter and by 131% year-on-year
The company's current ratio has surged by 134% QoQ and by 132% YoY
HLVX's debt is 84% smaller than its equity
HLVX's debt has dropped by 53% year-on-year
The equity has declined by 37% year-on-year and by 2.3% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.